Cargando…

A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices

Medical devices directly exposed to blood are commonly used to treat cardiovascular diseases. However, these devices are associated with inflammatory reactions leading to delayed healing, rejection of foreign material or device-associated thrombus formation. We developed a novel recombinant fusion p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, Meike-Kristin, Jost, Elena, Hohmann, Jan David, Searle, Amy Kate, Bongcaron, Viktoria, Song, Yuyang, Wendel, Hans Peter, Peter, Karlheinz, Krajewski, Stefanie, Wang, Xiaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466136/ https://www.ncbi.nlm.nih.gov/pubmed/34575580 http://dx.doi.org/10.3390/pharmaceutics13091504

Ejemplares similares

Thrombo-Inflammation: A Focus on NTPDase1/CD39
por: Morello, Silvana, et al.
Publicado: (2021)

In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications
por: Abraham, Meike-Kristin, et al.
Publicado: (2015)

Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3
por: Baqi, Younis, et al.
Publicado: (2020)

Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer
por: Abraham, Meike-Kristin, et al.
Publicado: (2017)

CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?
por: Grinthal, Alison, et al.
Publicado: (2006)

NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow
por: Favre, Julie, et al.
Publicado: (2023)

Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE
por: Jakovljevic, Marija, et al.
Publicado: (2019)

Appropriate Anti-Thrombotic/Anti-Thrombin Therapy for Thrombotic Lesions
por: Iqbal, Zafar, et al.
Publicado: (2012)

Increased NTPDase Activity in Lymphocytes during Experimental Sepsis
por: Bertoncheli, Claudia de Mello, et al.
Publicado: (2012)

NTPDase2+ Cells Generate Lingual Epithelia and Papillae
por: Li, Feng, et al.
Publicado: (2012)

Golgi-Located NTPDase1 of Leishmania major Is Required for Lipophosphoglycan Elongation and Normal Lesion Development whereas Secreted NTPDase2 Is Dispensable for Virulence
por: Sansom, Fiona M., et al.
Publicado: (2014)

Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin
por: Vorhoff, Thomas, et al.
Publicado: (2005)

Combined Blockade of ADP Receptors and PI3-Kinase p110β Fully Prevents Platelet and Leukocyte Activation during Hypothermic Extracorporeal Circulation
por: Krajewski, Stefanie, et al.
Publicado: (2012)

CD39/NTPDase-1 expression and activity in human umbilical vein endothelial cells are differentially regulated by leaf extracts from Rubus caesius and Rubus idaeus
por: Dudzinska, Dominika, et al.
Publicado: (2014)

Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy
por: Chatterjee, Madhumita, et al.
Publicado: (2020)

The Anti-Thrombotic Effects of PCSK9 Inhibitors
por: Péč, Martin Jozef, et al.
Publicado: (2023)

The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
por: Robson, Simon C., et al.
Publicado: (2006)

E-NTPDases in human airways: Regulation and relevance for chronic lung diseases
por: Burch, Lauranell H., et al.
Publicado: (2006)

NTPDases in the neuroendocrine hypothalamus: Possible energy regulators of the positive gonadotrophin feedback
por: Zsarnovszky, Attila, et al.
Publicado: (2009)

Generation and Characterization of Specific Antibodies to the Murine and Human Ectonucleotidase NTPDase8
por: Pelletier, Julie, et al.
Publicado: (2017)

E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities
por: Paes-Vieira, Lisvane, et al.
Publicado: (2021)

Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications
por: Michel, Tatjana, et al.
Publicado: (2017)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

The structure of the nucleoside triphosphate diphosphohydrolases (NTPDases) as revealed by mutagenic and computational modeling analyses
por: Kirley, Terence L., et al.
Publicado: (2006)

Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
por: Zanin, Rafael Fernandes, et al.
Publicado: (2012)

Ticlopidine in Its Prodrug Form Is a Selective Inhibitor of Human NTPDase1
por: Lecka, Joanna, et al.
Publicado: (2014)

Neuronal NTPDase3 Mediates Extracellular ATP Degradation in Trigeminal Nociceptive Pathway
por: Ma, Lihua, et al.
Publicado: (2016)

Ablation of NTPDase2+ cells inhibits the formation of filiform papillae in tongue tip
por: Li, Feng, et al.
Publicado: (2018)

Synthesis and biological evaluation of sulfamoyl benzamide derivatives as selective inhibitors for h-NTPDases
por: Zaigham, Zahid Hussain, et al.
Publicado: (2023)

Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)
por: Baqi, Younis, et al.
Publicado: (2008)

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8
por: Kukulski, F., et al.
Publicado: (2005)

Immobilization of NTPDase-1 from Trypanosoma cruzi and Development of an Online Label-Free Assay
por: Calil, Felipe Antunes, et al.
Publicado: (2016)

Knocking Down TcNTPDase-1 Gene Reduces in vitro Infectivity of Trypanosoma cruzi
por: Silva-Gomes, Natália Lins, et al.
Publicado: (2020)

Overexpression of TcNTPDase-1 Gene Increases Infectivity in Mice Infected with Trypanosoma cruzi
por: da Silva-Gomes, Natália Lins, et al.
Publicado: (2022)

Characterization of the Endometrial MSC Marker Ectonucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2/CD39L1) in Low- and High-Grade Endometrial Carcinomas: Loss of Stromal Expression in the Invasive Phenotypes
por: Rodríguez-Martínez, Aitor, et al.
Publicado: (2021)

Dental management of patients on anti-thrombotic agents
por: Lee, Jeong Keun
Publicado: (2018)

Monoclonal gammopathy of clinical significance: in vivo demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibody
por: Schell, Berenice, et al.
Publicado: (2020)

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

On the mechanism of anti-CD39 immune checkpoint therapy
por: Allard, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vm4iciqjdkieccpn1dbe54opkg